Risk Manag Healthc Policy
February 2021
Background: Co-trimoxazole is a broad-spectrum antibiotic associated with hyperkalemia.
Objective: To determine the incidence of hyperkalemia and its risk factors in patients receiving co-trimoxazole.
Materials And Methods: A retrospective observational study involving all patients who received co-trimoxazole between 1 January 2012 and 1 January 2013 was conducted.